Keep Me Logged In
Ron Cohen, Acorda Therapeutics CEO, joins CNBC's Meg Tirrell for an exclusive interview to discuss drug patents and respond to claims made by Hayman Capitals Kyle Bass regarding his fight against drug patents.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by